Burney Co. continued to hold its stake in shares of Thermo Fisher Scientific Inc (NYSE:TMO) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,969 shares of the medical research company’s stock at the end of the first quarter. Burney Co.’s holdings in Thermo Fisher Scientific were worth $302,000 as of its most recent SEC filing.
Other large investors have also made changes to their positions in the company. Toronto Dominion Bank boosted its position in Thermo Fisher Scientific by 53.5% in the first quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock valued at $16,450,000 after buying an additional 37,307 shares in the last quarter. Chevy Chase Trust Holdings Inc. boosted its position in Thermo Fisher Scientific by 1.8% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 338,114 shares of the medical research company’s stock valued at $51,935,000 after buying an additional 5,944 shares in the last quarter. Whalerock Point Partners LLC boosted its position in Thermo Fisher Scientific by 21.6% in the fourth quarter. Whalerock Point Partners LLC now owns 2,815 shares of the medical research company’s stock valued at $398,000 after buying an additional 500 shares in the last quarter. Tompkins Financial Corp boosted its position in Thermo Fisher Scientific by 0.8% in the first quarter. Tompkins Financial Corp now owns 5,183 shares of the medical research company’s stock valued at $733,000 after buying an additional 40 shares in the last quarter. Finally, Huntington National Bank boosted its position in Thermo Fisher Scientific by 6.9% in the first quarter. Huntington National Bank now owns 186,907 shares of the medical research company’s stock valued at $28,708,000 after buying an additional 12,025 shares in the last quarter. Institutional investors own 86.93% of the company’s stock.
Thermo Fisher Scientific Inc (NYSE TMO) opened at 182.18 on Friday. The firm has a market capitalization of $71.27 billion, a PE ratio of 33.23 and a beta of 1.06. Thermo Fisher Scientific Inc has a 12 month low of $139.07 and a 12 month high of $182.86. The company’s 50-day moving average price is $176.35 and its 200 day moving average price is $162.18.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, April 26th. The medical research company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.02 by $0.06. The firm had revenue of $4.77 billion during the quarter, compared to analyst estimates of $4.68 billion. Thermo Fisher Scientific had a return on equity of 15.73% and a net margin of 11.58%. The company’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the previous year, the company posted $1.80 EPS. On average, equities research analysts predict that Thermo Fisher Scientific Inc will post $9.23 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Shareholders of record on Friday, September 15th will be issued a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.95%.
TRADEMARK VIOLATION NOTICE: This piece of content was published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://stocknewstimes.com/2017/07/23/thermo-fisher-scientific-inc-tmo-position-maintained-by-burney-co.html.
TMO has been the subject of several recent research reports. Morgan Stanley upped their price objective on Thermo Fisher Scientific from $186.00 to $192.00 and gave the stock an “overweight” rating in a research report on Friday, April 28th. Barclays PLC reaffirmed an “overweight” rating and set a $190.00 price objective (up from $175.00) on shares of Thermo Fisher Scientific in a research report on Tuesday, May 9th. Deutsche Bank AG upped their price objective on Thermo Fisher Scientific from $163.00 to $188.00 and gave the stock a “buy” rating in a research report on Friday, April 28th. Leerink Swann set a $187.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, April 27th. Finally, Cowen and Company reaffirmed an “outperform” rating and set a $185.00 price objective (up from $175.00) on shares of Thermo Fisher Scientific in a research report on Saturday, April 29th. One analyst has rated the stock with a hold rating, sixteen have given a buy rating and two have assigned a strong buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $187.88.
In other Thermo Fisher Scientific news, insider Thomas W. Loewald sold 1,532 shares of the business’s stock in a transaction that occurred on Thursday, April 27th. The stock was sold at an average price of $168.76, for a total transaction of $258,540.32. Following the completion of the sale, the insider now directly owns 41,277 shares of the company’s stock, valued at approximately $6,965,906.52. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of the business’s stock in a transaction that occurred on Monday, June 5th. The stock was sold at an average price of $176.26, for a total value of $440,650.00. Following the sale, the chief financial officer now directly owns 37,790 shares of the company’s stock, valued at $6,660,865.40. The disclosure for this sale can be found here. Insiders have sold a total of 28,720 shares of company stock valued at $4,960,764 over the last three months. Corporate insiders own 0.49% of the company’s stock.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).
Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.
